We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HSBA:LSEHSBC Holdings Plc Analysis

Data as of 2026-06-12 - not real-time

£1,321.80

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

HSBC shares are trading at 1321.8 GBp, positioned below the 20‑day SMA (1360) but above the 200‑day SMA (1181), suggesting a transitional bullish bias supported by an overall bullish trend direction and increasing volume. The RSI sits at 45, indicating neutral momentum, while the MACD histogram is negative, hinting at short‑term bearish pressure. Despite this, the price remains above the key support level of 1267 and well under the 52‑week high of 1416, leaving room for upside. The stock trades at a forward PE of 9.3 and a trailing PE of 14.5, both comfortably below the industry average PE of 16.6, pointing to a valuation advantage. A dividend yield of 4.3% with a payout ratio of ~61% underscores attractive income generation. Operating margins are robust at 50.7% and profit margins at 35%, while ROE of 11.6% reflects solid profitability. The balance sheet shows ample cash (≈£1.16 tn) relative to debt, mitigating solvency concerns. Volatility over the past 30 days is elevated at 33 % but the beta of 0.73 indicates lower systematic risk than the market. Recent news highlights regulatory scrutiny in Hong Kong, which could pressure Asian earnings, yet the broader market sentiment is in “Extreme Greed” territory. Upside potential is estimated around 8 % based on the upside/downside metric and analyst target median of 1474 GBp.
Overall, the combination of undervalued multiples, strong dividend, and resilient earnings supports a positive outlook, though regulatory and geopolitical factors warrant caution.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Price above 200‑day SMA indicating long‑term support
  • Increasing volume supporting bullish momentum
  • Attractive dividend yield of 4.3% with sustainable payout

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued PE relative to industry peers
  • Analyst median target price suggesting ~11% upside
  • Strong profitability metrics and cash position

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Exposure to regulatory headwinds in Hong Kong and UK
  • Stable dividend income for income‑focused investors
  • Solid balance sheet but elevated geopolitical risk

Key Metrics & Analysis

Financial Health

Revenue Growth3.30%
Profit Margin34.98%
P/E Ratio14.5
ROE11.61%
ROA0.72%
P/B Ratio1.7
Industry P/E16.6

Technical Analysis

TrendBullish
RSI45.1
Support£1,267.20
Resistance£1,416.80
MA 20£1,360.26
MA 50£1,334.45
MA 200£1,181.61
MACDBearish
VolumeIncreasing
Fear & Greed Index86.71

Valuation

Target Price£1,426.35
Upside/Downside7.91%
GradeUndervalued
TypeValue
Dividend Yield4.30%

Risk Assessment

Beta0.73
Volatility33.04%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.